サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1282769

アレルギー免疫療法の世界市場（2023年～2033年）

Allergy Immunotherapy Market Report 2023-2033
出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=199.66円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

アレルギー免疫療法の世界市場（2023年～2033年）
出版日: 2023年05月31日
発行: Visiongain Reports Ltd.
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー免疫療法の市場規模は、2022年の19億750万米ドルに達し、2023年から2033年までの予測期間中のCAGRは7.6%となっています。特に先進諸国における医療支出の増加は、市場の成長を促進しています。

当レポートでは、世界のアレルギー免疫療法市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19感染症の影響分析
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 新規参入業者の脅威
  • PEST分析

第4章 アレルギー免疫療法市場分析：治療タイプ別

  • 主な調査結果
  • 治療タイプセグメント：市場魅力度指数
  • アレルギー免疫療法市場規模の推定と予測：治療タイプ別
  • 皮下免疫療法（SCIT）
  • 舌下免疫療法（SLIT）

第5章 アレルギー免疫療法市場分析：アレルギータイプ別

  • 主な調査結果
  • アレルギータイプセグメント：市場魅力度指数
  • アレルギー免疫療法市場規模の推定と予測：アレルギータイプ別
  • アレルギー性鼻炎
  • 喘息
  • その他

第6章 アレルギー免疫療法市場分析：流通チャネル別

  • 主な調査結果
  • 流通チャネルセグメント：市場魅力度指数
  • アレルギー免疫療法市場規模の推定と予測：販売チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 アレルギー免疫療法市場分析：地域別

  • 主な調査結果
  • 地域の市場規模の推定と予測

第8章 北米のアレルギー免疫療法市場分析

第9章 欧州のアレルギー免疫療法市場分析

第10章 アジア太平洋のアレルギー免疫療法市場分析

第11章 ラテンアメリカのアレルギー免疫療法市場分析

第12章 中東・アフリカアレルギー免疫療法市場分析

第13章 企業プロファイル

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Adamis Pharmaceuticals Corporation
  • Allergy Therapeutics
  • Allergopharma
  • DVB Technologies SA
  • DESENTUM OY
  • HAL Allergy Group
  • HISHOH Biopharma
  • HollisterStier Allergy（Jubilant Pharma Company）
  • LETIPharma
  • Stallergenes Greer

第14章 結論と推奨事項

  • 結論
  • 市場参入企業への推奨事項
図表

List of Tables

  • Table 1 Allergy Immunotherapy Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
  • Table 2 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 7 Subcutaneous Immunotherapy (SCIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 8 Sublingual Immunotherapy (SLIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 9 Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 10 Allergic Rhinitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 11 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 13 Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 14 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 15 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 16 Online Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 17 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 18 North America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 19 North America Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 20 North America Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 21 North America Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 22 U.S. Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 23 Canada Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 24 Europe Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 25 Europe Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 26 Europe Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 27 Europe Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 28 Germany Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 29 UK Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 30 France Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 31 Italy Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 32 Spain Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 33 Russia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 34 Rest of Europe Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 35 Asia-Pacific Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 36 Asia-Pacific Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 37 Asia-Pacific Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 38 Asia-Pacific Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 39 Japan Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 40 China Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 41 India Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 42 Australia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 43 South Korea Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 44 South-East Asia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 45 Rest of Asia Pacific Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 46 Latin America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 47 Latin America Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 48 Latin America Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 49 Latin America Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 50 Brazil Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 51 Mexico Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 52 Argentina Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 53 Colombia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 54 Rest of Latin America Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 55 MEA Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 56 MEA Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 57 MEA Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 58 MEA Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 59 GCC Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 60 South Africa Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 61 Rest of MEA Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 62 Aimmune Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 63 Aimmune Therapeutics: Product Benchmarking
  • Table 64 ALK-Abello A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 65 ALK-Abello A/S: Product Benchmarking
  • Table 66 Adamis Pharmaceuticals Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 67 Adamis Pharmaceuticals Corporation: Product Benchmarking
  • Table 68 Adamis Pharmaceuticals Corporation: Strategic Outlook
  • Table 69 Allergy Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 70 Allergy Therapeutics: Product Benchmarking
  • Table 71 Allergopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 72 Allergopharma: Product Benchmarking
  • Table 73 DVB Technologies SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 74 DVB Technologies SA: Product Benchmarking
  • Table 75 DVB Technologies SA: Strategic Outlook
  • Table 76 DESENTUM OY: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 DESENTUM OY: Product Benchmarking
  • Table 78 HAL Allergy Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 HAL Allergy Group: Product Benchmarking
  • Table 80 HISHOH Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 HISHOH Biopharma: Product Benchmarking
  • Table 82 HISHOH Biopharma: Strategic Outlook
  • Table 83 HollisterStier Allergy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 84 HollisterStier Allergy: Product Benchmarking
  • Table 85 LETIPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 LETIPharma: Product Benchmarking
  • Table 87 Stallergenes Greer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Stallergenes Greer: Product Benchmarking
  • Table 89 Stallergenes Greer: Strategic Outlook

List of Figures

  • Figure 1 Allergy Immunotherapy Market Segmentation
  • Figure 2 Allergy Immunotherapy Market by Treatment Type: Market Attractiveness Index
  • Figure 3 Allergy Immunotherapy Market by Allergy Type: Market Attractiveness Index
  • Figure 4 Allergy Immunotherapy Market by Distribution Channel: Market Attractiveness Index
  • Figure 5 Allergy Immunotherapy Market Attractiveness Index by Region
  • Figure 6 Allergy Immunotherapy Market: Market Dynamics
  • Figure 7 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): "V" Shaped Recovery
  • Figure 8 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): "U" Shaped Recovery
  • Figure 9 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): "W" Shaped Recovery
  • Figure 10 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): "L" Shaped Recovery
  • Figure 11 Allergy Immunotherapy Market: Porter's Five Forces Analysis
  • Figure 12 Allergy Immunotherapy Market: PEST Analysis
  • Figure 13 Allergy Immunotherapy Market Attractiveness Index by Treatment Type
  • Figure 14 Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
  • Figure 15 Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023, 2028, 2033 (%)
  • Figure 16 Subcutaneous Immunotherapy (SCIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 17 Subcutaneous Immunotherapy (SCIT) Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 18 Sublingual Immunotherapy (SLIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 19 Sublingual Immunotherapy (SLIT) Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 20 Allergy Immunotherapy Market Attractiveness Index by Treatment Type
  • Figure 21 Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
  • Figure 22 Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023, 2028, 2033 (%)
  • Figure 23 Allergic Rhinitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 24 Allergic Rhinitis Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 25 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 26 Asthma Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 27 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 28 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Allergy Immunotherapy Market Attractiveness Index by Distribution Channel
  • Figure 30 Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
  • Figure 31 Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023, 2028, 2033 (%)
  • Figure 32 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 33 Hospital Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 35 Retail Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Online Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 37 Online Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Allergy Immunotherapy Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
  • Figure 39 Allergy Immunotherapy Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 40 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 41 North America Allergy Immunotherapy Market Attractiveness Index
  • Figure 42 North America Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 43 North America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 44 North America Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 45 North America Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
  • Figure 46 North America Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
  • Figure 47 North America Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
  • Figure 48 North America Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
  • Figure 49 North America Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
  • Figure 50 North America Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 51 U.S. Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 52 Canada Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 53 Europe Allergy Immunotherapy Market Attractiveness Index
  • Figure 54 Europe Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 55 Europe Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 56 Europe Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 57 Europe Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
  • Figure 58 Europe Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
  • Figure 59 Europe Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
  • Figure 60 Europe Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
  • Figure 61 Europe Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
  • Figure 62 Europe Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 63 Germany Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 64 UK Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 65 France Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 66 Italy Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 67 Spain Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 68 Russia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 69 Rest of Europe Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 70 Asia Pacific Allergy Immunotherapy Market Attractiveness Index
  • Figure 71 Asia Pacific Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 72 Asia Pacific Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 73 Asia Pacific Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 74 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
  • Figure 75 Asia Pacific Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
  • Figure 76 Asia Pacific Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
  • Figure 77 Asia Pacific Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
  • Figure 78 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
  • Figure 79 Asia Pacific Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 80 Japan Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 81 China Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 82 India Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 83 Australia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 84 South Korea Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 85 South-East Asia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 86 Rest of Asia Pacific Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 87 Latin America Allergy Immunotherapy Market Attractiveness Index
  • Figure 88 Latin America Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 89 Latin America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 90 Latin America Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 91 Latin America Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
  • Figure 92 Latin America Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
  • Figure 93 Latin America Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
  • Figure 94 Latin America Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
  • Figure 95 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
  • Figure 96 Latin America Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 97 Brazil Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 98 Mexico Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 99 Argentina Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 100 Colombia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 101 Rest of Latin America Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 102 MEA Allergy Immunotherapy Market Attractiveness Index
  • Figure 103 MEA Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 104 MEA Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 105 MEA Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 106 MEA Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
  • Figure 107 MEA Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
  • Figure 108 MEA Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
  • Figure 109 MEA Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
  • Figure 110 MEA Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
  • Figure 111 MEA Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 112 GCC Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 113 South Africa Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 114 Rest of MEA Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 115 Adamis Pharmaceuticals Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 116 Adamis Pharmaceuticals Corporation: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 117 Allergy Therapeutics: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 118 Allergy Therapeutics: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 119 DVB Technologies SA: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 120 DVB Technologies SA: R&D, 2017-2022 (US$ Million, AGR%)
目次
Product Code: PHA1244

The global Allergy Immunotherapy market was valued US$1,907.5 million in 2022 and is projected to grow at a CAGR of 7.6% during the forecast period 2023-2033..

“The Allergy Immunotherapy Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Significant advancements in allergy immunotherapy techniques have propelled the industry forward. The introduction of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) has expanded treatment options, making immunotherapy more accessible and convenient for patients. Additionally, the development of allergen-specific immunotherapies and modified formulations, such as recombinant allergens and adjuvants, has improved treatment efficacy and safety.

Rising healthcare expenditure, particularly in developed countries, has contributed to the growth of the allergy immunotherapy industry. As individuals and healthcare systems prioritize preventive care and long-term management of chronic conditions, allergy immunotherapy has gained recognition as a cost-effective approach. This has fuelled investments in research, innovation, and infrastructure to meet the growing demand.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the allergy immunotherapy market evolving?
  • What is driving and restraining the allergy immunotherapy market?
  • How will each allergy immunotherapy submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each allergy immunotherapy submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading allergy immunotherapy markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the allergy immunotherapy projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of allergy immunotherapy projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the allergy immunotherapy market?
  • Where is the allergy immunotherapy market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the allergy immunotherapy market today, and over the next 10 years:

  • Our 187-page report provides 89 tables and 120 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the allergy immunotherapy market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Treatment Type

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Allergy Type

  • Allergic Rhinitis
  • Asthma
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Allergy Immunotherapy Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Adamis Pharmaceuticals Corporation
  • Allergy Therapeutics
  • Allergopharma
  • DBV Technologies
  • DESENTUM OY
  • HAL Allergy B.V
  • HISHOH Biopharma
  • HollisterStier Allergy (Jubilant Pharma Company)
  • LETI Pharma
  • Stallergenes Greer

Overall world revenue for Allergy Immunotherapy Market, 2023 to 2033 in terms of value the market will surpass US$2,021.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Allergy Immunotherapy Market, 2023 to 2033 report help you?

In summary, our 180+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Allergy Immunotherapy Market, 2023 to 2033 Market, with forecasts for treatment type, allergy type, and distribution channel each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 20 key national markets - See forecasts for the Allergy Immunotherapy Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 12 of the major companies involved in the Allergy Immunotherapy Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Allergy Immunotherapy Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Allergy Immunotherapy Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Burden of Various Types of Allergies
      • 3.2.1.2 Launch of New Sublingual Immunotherapies in Emerging Economies
      • 3.2.1.3 Increasing Allergic Rhinitis and Asthma Cases
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Lack of Awareness about Allergy and Treatments
      • 3.2.2.2 Drawbacks Associated with the use of Allergy Immunotherapy
    • 3.2.3 Market Opportunities
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Buyer Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Allergy Immunotherapy Market Analysis by Treatment Type

  • 4.1 Key Findings
  • 4.2 Treatment Type Segment: Market Attractiveness Index
  • 4.3 Allergy Immunotherapy Market Size Estimation and Forecast by Treatment Type
  • 4.4 Subcutaneous Immunotherapy (SCIT)
    • 4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Sublingual Immunotherapy (SLIT)
    • 4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Allergy Immunotherapy Market Analysis by Allergy Type

  • 5.1 Key Findings
  • 5.2 Allergy Type Segment: Market Attractiveness Index
  • 5.3 Allergy Immunotherapy Market Size Estimation and Forecast by Allergy Type
  • 5.4 Allergic Rhinitis
    • 5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Asthma
    • 5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Others
    • 5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Allergy Immunotherapy Market Analysis by Distribution Channel

  • 6.1 Key Findings
  • 6.2 Distribution Channel Segment: Market Attractiveness Index
  • 6.3 Allergy Immunotherapy Market Size Estimation and Forecast by Distribution Channel
  • 6.4 Hospital Pharmacy
    • 6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Retail Pharmacy
    • 6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Online Pharmacy
    • 6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Allergy Immunotherapy Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Allergy Immunotherapy Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Allergy Immunotherapy Market Attractiveness Index
  • 8.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 8.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
  • 8.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
  • 8.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
  • 8.8 U.S. Allergy Immunotherapy Market Analysis
  • 8.9 Canada Allergy Immunotherapy Market Analysis

9 Europe Allergy Immunotherapy Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Allergy Immunotherapy Market Attractiveness Index
  • 9.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 9.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
  • 9.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
  • 9.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
  • 9.8 Germany Allergy Immunotherapy Market Analysis
  • 9.9 UK Allergy Immunotherapy Market Analysis
  • 9.10 France Allergy Immunotherapy Market Analysis
  • 9.11 Italy Allergy Immunotherapy Market Analysis
  • 9.12 Spain Allergy Immunotherapy Market Analysis
  • 9.13 Russia Allergy Immunotherapy Market Analysis
  • 9.14 Rest of Europe Allergy Immunotherapy Market Analysis

10 Asia Pacific Allergy Immunotherapy Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Allergy Immunotherapy Market Attractiveness Index
  • 10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 10.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
  • 10.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
  • 10.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
  • 10.8 Japan Allergy Immunotherapy Market Analysis
  • 10.9 China Allergy Immunotherapy Market Analysis
  • 10.10 India Allergy Immunotherapy Market Analysis
  • 10.11 Australia Allergy Immunotherapy Market Analysis
  • 10.12 South Korea Allergy Immunotherapy Market Analysis
  • 10.13 South-East Asia Allergy Immunotherapy Market Analysis
  • 10.14 Rest of Asia Pacific Allergy Immunotherapy Market Analysis

11 Latin America Allergy Immunotherapy Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Allergy Immunotherapy Market Attractiveness Index
  • 11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 11.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
  • 11.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
  • 11.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
  • 11.8 Brazil Allergy Immunotherapy Market Analysis
  • 11.9 Mexico Allergy Immunotherapy Market Analysis
  • 11.10 Argentina Allergy Immunotherapy Market Analysis
  • 11.11 Colombia Allergy Immunotherapy Market Analysis
  • 11.12 Rest of Latin America Allergy Immunotherapy Market Analysis

12 MEA Allergy Immunotherapy Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Allergy Immunotherapy Market Attractiveness Index
  • 12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 12.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
  • 12.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
  • 12.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
  • 12.8 GCC Allergy Immunotherapy Market Analysis
  • 12.9 South Africa Allergy Immunotherapy Market Analysis
  • 12.10 Rest of MEA Allergy Immunotherapy Market Analysis

13 Company Profiles

  • 13.1 Aimmune Therapeutics
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis
    • 13.1.4 Product Benchmarking
  • 13.2 ALK-Abello A/S
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Product Benchmarking
  • 13.3 Adamis Pharmaceuticals Corporation
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2017-2022
      • 13.3.3.2 R&D, 2017-2022
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Allergy Therapeutics
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2017-2022
      • 13.4.3.2 R&D, 2017-2022
    • 13.4.4 Product Benchmarking
  • 13.5 Allergopharma
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Product Benchmarking
  • 13.6 DVB Technologies SA
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
      • 13.6.3.1 Net Revenue, 2017-2022
      • 13.6.3.2 R&D, 2017-2022
    • 13.6.4 Product Benchmarking
    • 13.6.5 Strategic Outlook
  • 13.7 DESENTUM OY
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Product Benchmarking
  • 13.8 HAL Allergy Group
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Product Benchmarking
  • 13.9 HISHOH Biopharma
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Product Benchmarking
    • 13.9.4 Strategic Outlook
  • 13.10 HollisterStier Allergy (Jubilant Pharma Company)
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Product Benchmarking
  • 13.11 LETIPharma
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Product Benchmarking
  • 13.12 Stallergenes Greer
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Product Benchmarking
    • 13.12.4 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from
  • 14.2 Recommendations for Market Players